Alina Georgiana Apostol

Dr. Alina Georgiana Apostol

Clinical Rehabilitation Hospital, Iaşi, Romania

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DANIELA MARIA TANASEDANIELA MARIA TANASE
DANIELA MARIA TANASE
AAAlina Georgiana Apostol
Alina Georgiana Apostol
CCClaudia Florida Costea
Claudia Florida Costea
CTClaudia Cristina Tarniceriu
Claudia Cristina Tarniceriu
ITIonut Tudorancea
Ionut Tudorancea
Ionela Lacramioara SerbanIonela Lacramioara Serban
Ionela Lacramioara Serban
Arterial hypertension (HTN) is one of the most prevalent entities globally, characterized by increased incidence and heterogeneous pathophysiology. Among possible etiologies, oxidative stress (OS) is currently extensively studied, with emerging evidence showing its involvement in endothelial dysfunction and in different cardiovascular diseases (CVD) such as HTN, as well as its potential as a therapeutic target. While there is a clear physiological equilibrium between reactive oxygen species (ROS) and antioxidants essential for many cellular functions, excessive levels of ROS lead to vascular cell impairment with decreased nitric oxide (NO) availability and vasoconstriction, which promotes HTN. On the other hand, transcription factors such as nuclear factor erythroid factor 2-related factor 2 (Nrf2) mediate antioxidant response pathways and maintain cellular reduction–oxidation homeostasis, exerting protective effects. In this review, we describe the relationship between OS and hypertension-induced endothelial dysfunction and the involvement and therapeutic potential of Nrf2 in HTN.